These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 23873356)

  • 21. Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series.
    Nevoux P; Ouzzane A; Ahmed HU; Emberton M; Montironi R; Presti JC; Villers A
    BJU Int; 2012 Aug; 110(4):517-23. PubMed ID: 22192756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol.
    Ouzaid I; Xylinas E; Campeggi A; Hoznek A; Vordos D; Abbou CC; Vacherot F; Salomon L; de la Taille A; Ploussard G
    World J Urol; 2013 Aug; 31(4):869-74. PubMed ID: 22116600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
    Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
    BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading.
    Ouzzane A; Puech P; Lemaitre L; Leroy X; Nevoux P; Betrouni N; Haber GP; Villers A
    Urology; 2011 Dec; 78(6):1356-62. PubMed ID: 21840577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy.
    Roethke M; Anastasiadis AG; Lichy M; Werner M; Wagner P; Kruck S; Claussen CD; Stenzl A; Schlemmer HP; Schilling D
    World J Urol; 2012 Apr; 30(2):213-8. PubMed ID: 21512807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence of transition zone prostate cancer diagnosed by transperineal template-guided mapping biopsy: implications for treatment planning.
    Patel V; Merrick GS; Allen ZA; Andreini H; Taubenslag W; Singh S; Butler WM; Adamovich E; Bittner N
    Urology; 2011 May; 77(5):1148-52. PubMed ID: 21334045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature.
    Chun FK; Epstein JI; Ficarra V; Freedland SJ; Montironi R; Montorsi F; Shariat SF; Schröder FH; Scattoni V
    Eur Urol; 2010 Dec; 58(6):851-64. PubMed ID: 20884114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of additional "extreme" anterior apical needle biopsies in the initial detection of prostate cancer.
    Moussa AS; Meshref A; Schoenfield L; Masoud A; Abdel-Rahman S; Li J; Flazoura S; Magi-Galluzzi C; Fergany A; Fareed K; Jones JS
    Urology; 2010 May; 75(5):1034-9. PubMed ID: 20080294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.
    Hambrock T; Somford DM; Hoeks C; Bouwense SA; Huisman H; Yakar D; van Oort IM; Witjes JA; Fütterer JJ; Barentsz JO
    J Urol; 2010 Feb; 183(2):520-7. PubMed ID: 20006859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution of tumour foci.
    Davis JW; Kim J; Ward JF; Wang X; Nakanishi H; Babaian RJ; Troncoso P
    BJU Int; 2010 May; 105(10):1386-91. PubMed ID: 19888979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol.
    de la Rosette JJ; Wink MH; Mamoulakis C; Wondergem N; ten Kate FJ; Zwinderman K; de Reijke TM; Wijkstra H
    J Urol; 2009 Oct; 182(4):1329-36. PubMed ID: 19683269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors.
    Haarer CF; Gopalan A; Tickoo SK; Scardino PT; Eastham JA; Reuter VE; Fine SW
    J Urol; 2009 Oct; 182(4):1337-41. PubMed ID: 19683261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of prostate cancer originating from the transition zone.
    King CR; Ferrari M; Brooks JD
    Urol Oncol; 2009; 27(6):592-7. PubMed ID: 18799332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy.
    Al-Ahmadie HA; Tickoo SK; Olgac S; Gopalan A; Scardino PT; Reuter VE; Fine SW
    Am J Surg Pathol; 2008 Feb; 32(2):229-35. PubMed ID: 18223325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
    Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
    Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
    Sakai I; Harada K; Kurahashi T; Yamanaka K; Hara I; Miyake H
    Int J Urol; 2006 Apr; 13(4):368-72. PubMed ID: 16734852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.
    Anastasiadis AG; Lichy MP; Nagele U; Kuczyk MA; Merseburger AS; Hennenlotter J; Corvin S; Sievert KD; Claussen CD; Stenzl A; Schlemmer HP
    Eur Urol; 2006 Oct; 50(4):738-48; discussion 748-9. PubMed ID: 16630688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study.
    Soos G; Tsakiris I; Szanto J; Turzo C; Haas PG; Dezso B
    Eur Urol; 2005 Nov; 48(5):739-44. PubMed ID: 16203079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project.
    Pelzer AE; Bektic J; Berger AP; Halpern EJ; Koppelstätter F; Klauser A; Rehder P; Horninger W; Bartsch G; Frauscher F
    Eur Urol; 2005 Dec; 48(6):916-21; discussion 921. PubMed ID: 16126324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Allsbrook WC; Amin MB; Egevad LL;
    Am J Surg Pathol; 2005 Sep; 29(9):1228-42. PubMed ID: 16096414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.